Skip to content

Using NIRS to Evaluate Splanchnic Oxygenation During Blood Transfusion in Preterm Infant

The Effect of Enteral Feeding on Splanchnic Oxygenation During Blood Transfusion in Preterm Infants

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06663085
Enrollment
42
Registered
2024-10-29
Start date
2024-10-30
Completion date
2025-01-15
Last updated
2024-10-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Enteral Feeds, NIRS, PreTerm Neonate, Splanchnic Oxygenation

Keywords

transfusion, nirs, splanchnic oxygenation, preterm neonate, enteral feeds

Brief summary

To evaluate the differences splanchnic oxygen saturation in preterm infants receiving red blood cell transfusion with and without enteral feeding, and their outcomes.

Detailed description

using NIRS to evaluate splanchnic oxygenation

Interventions

DIETARY_SUPPLEMENTEnteral feeding

intervention group received enteral feeding breastmilk during transfusion

Sponsors

Gadjah Mada University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

control group: not received enteral feeding during transfusion intervention group: received enteral feeding

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Infant with gestational age \< 37 weeks * Planned to receive blood transfusion * Had received minimum 25 ml/kg/day enteral feeding * in stable condition

Exclusion criteria

* Infant with multiple congenital anomalies * Infant with suspected/confirmed genetic anomalies * Parents or family did not sign the informed consent

Design outcomes

Primary

MeasureTime frameDescription
cerebral splanchnic oxygenation ratio using nirsfrom enrollment to 48 hours after transfusionpercentage of splanchnic oxygenaation divided with cerebral oxygenation

Countries

Indonesia

Contacts

Primary Contactleksmana hidayatullah, medical doctor
leksmanahidayatullah@gmail.com+6281284298440

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026